Opposing lineage specifiers induce a protumor hybrid identity state in lung adenocarcinoma
Genes & Development · 01.09.2025 · 39 (17-18) · 1081-1105
DOI: 10.1101/gad.352742.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, online erschienen am 12.06.2025. Verfasst von Gabriela Fort und 7 weiteren Autor:innen. Beteiligte Einrichtung: Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, Lung Neoplasms, Adenocarcinoma of Lung, Cell Lineage. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, American Lung Association.
Abstract (Originalsprache)
Lineage plasticity is critical for tumor progression and therapy resistance, but the molecular mechanisms underlying cell identity shifts in cancer remain poorly understood. In lung adenocarcinoma (LUAD), the loss of pulmonary lineage fidelity and acquisition of alternate identity programs converge on hybrid identity (hybrid ID) states, which are postulated to be key intermediates in LUAD evolution and are characterized by the coactivation of developmentally incompatible identity programs within individual cells. Here, we uncover a previously unrecognized role for the gastrointestinal transcriptional regulator HNF4α in driving tumor growth and hybrid ID states in LUAD. In LUAD cells expressing the lung lineage specifier NKX2-1, HNF4α induces a GI/liver-like state by directly binding and activating its canonical targets. HNF4α also disrupts NKX2-1 genomic localization and dampens pulmonary identity within hybrid ID LUAD. We show that this hybrid ID state is maintained by sustained RAS/MEK signaling. Inhibition of the RAS/MEK signaling cascade augments NKX2-1 chromatin binding at pulmonary-specific genes and induces drug resistance-associated pulmonary signatures. Finally, we demonstrate that HNF4α depletion sensitizes LUAD cells to KRAS G12D inhibition. Collectively, our data show that coexpression of opposing lineage specifiers is a novel mechanism of identity dysregulation in LUAD that influences both tumor progression and response to targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA.
- Department of Oncological Sciences, University of Utah, Salt Lake City, Utah 84112, USA.
- Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA; eric.snyder@hci.utah.edu.
- Department of Pathology, University of Utah, Salt Lake City, Utah 84112, USA.
Förderung
- NCI NIH HHS
- National Institutes of Health
- American Lung Association
- American Cancer Society
- Department of Pathology
- Huntsman Cancer Institute/Huntsman Cancer Foundation, University of Utah
- NIH/National Cancer Institute
- Genetics Training
Zitieren
APA
Fort, G., Arnold, H., Camolotto, S. A., O'Toole, K., Tariq, R., Waters, A., Gillis, K., & Snyder, E. L. (2025). Opposing lineage specifiers induce a protumor hybrid identity state in lung adenocarcinoma. Genes & Development, 39(17-18), 1081-1105. https://doi.org/10.1101/gad.352742.125
Vancouver
Fort G, Arnold H, Camolotto SA, O'Toole K, Tariq R, Waters A, et al. Opposing lineage specifiers induce a protumor hybrid identity state in lung adenocarcinoma. Genes & Development. 2025;39(17-18):1081-1105. doi:10.1101/gad.352742.125
BibTeX
@article{Fort2025,
author = {Fort, Gabriela and Arnold, Henry and Camolotto, Soledad A and O'Toole, Kayla and Tariq, Rushmeen and Waters, Anna and Gillis, Katherine and Snyder, Eric L},
title = {Opposing lineage specifiers induce a protumor hybrid identity state in lung adenocarcinoma},
journal = {Genes & Development},
year = {2025},
volume = {39},
number = {17-18},
pages = {1081--1105},
doi = {10.1101/gad.352742.125}
}
EUVIMED